2024 Q4 Form 10-Q Financial Statement
#000095017024126366 Filed on November 13, 2024
Income Statement
Concept | 2024 Q4 | 2024 Q3 | 2023 Q3 |
---|---|---|---|
Revenue | $0.00 | ||
YoY Change | -100.0% | ||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $8.269M | ||
YoY Change | 37.43% | ||
% of Gross Profit | |||
Research & Development | $29.19M | $32.76M | |
YoY Change | -10.89% | 53.55% | |
% of Gross Profit | |||
Depreciation & Amortization | $558.0K | $1.245M | |
YoY Change | -55.18% | 83.9% | |
% of Gross Profit | |||
Operating Expenses | $38.77M | $41.03M | |
YoY Change | -5.51% | 50.0% | |
Operating Profit | -$38.77M | -$16.28M | |
YoY Change | 138.12% | ||
Interest Expense | $1.353M | ||
YoY Change | 454.51% | ||
% of Operating Profit | |||
Other Income/Expense, Net | $4.278M | -$23.00K | |
YoY Change | -18700.0% | -28.13% | |
Pretax Income | -$39.70M | ||
YoY Change | 94.63% | ||
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$34.49M | -$39.70M | |
YoY Change | -13.12% | 94.63% | |
Net Earnings / Revenue | |||
Basic Earnings Per Share | -$0.80 | -$23.27 | |
Diluted Earnings Per Share | -$0.80 | -$0.97 | |
COMMON SHARES | |||
Basic Shares Outstanding | 43.17M | 43.15M | 664.7K |
Diluted Shares Outstanding | 43.16M | 664.7K |
Balance Sheet
Concept | 2024 Q4 | 2024 Q3 | 2023 Q3 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $321.6M | $77.27M | |
YoY Change | 316.16% | ||
Cash & Equivalents | $104.7M | $22.97M | |
Short-Term Investments | $216.9M | $54.31M | |
Other Short-Term Assets | $3.787M | $2.136M | |
YoY Change | 77.29% | ||
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $325.4M | $79.41M | |
YoY Change | 309.74% | ||
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $3.151M | $11.07M | |
YoY Change | -71.54% | ||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $1.876M | $2.005M | |
YoY Change | -6.43% | ||
Total Long-Term Assets | $13.82M | $13.08M | |
YoY Change | 5.71% | ||
TOTAL ASSETS | |||
Total Short-Term Assets | $325.4M | $79.41M | |
Total Long-Term Assets | $13.82M | $13.08M | |
Total Assets | $339.2M | $92.49M | |
YoY Change | 266.75% | ||
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $9.932M | $3.022M | |
YoY Change | 228.66% | ||
Accrued Expenses | $13.69M | $10.00M | |
YoY Change | 36.85% | ||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | |
YoY Change | |||
Long-Term Debt Due | $931.0K | $897.0K | |
YoY Change | 3.79% | ||
Total Short-Term Liabilities | $30.99M | $16.87M | |
YoY Change | 83.63% | ||
LONG-TERM LIABILITIES | |||
Long-Term Debt | $237.0K | $1.078M | |
YoY Change | -78.01% | ||
Other Long-Term Liabilities | $296.0K | $5.766M | |
YoY Change | -94.87% | ||
Total Long-Term Liabilities | $296.0K | $6.844M | |
YoY Change | -95.68% | ||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $30.99M | $16.87M | |
Total Long-Term Liabilities | $296.0K | $6.844M | |
Total Liabilities | $36.49M | $23.72M | |
YoY Change | 53.83% | ||
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$226.0M | ||
YoY Change | |||
Common Stock | $528.6M | ||
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $302.7M | $68.77M | |
YoY Change | |||
Total Liabilities & Shareholders Equity | $339.2M | $92.49M | |
YoY Change | 266.75% |
Cashflow Statement
Concept | 2024 Q4 | 2024 Q3 | 2023 Q3 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$34.49M | -$39.70M | |
YoY Change | -13.12% | 94.63% | |
Depreciation, Depletion And Amortization | $558.0K | $1.245M | |
YoY Change | -55.18% | 83.9% | |
Cash From Operating Activities | -$27.49M | -$33.85M | |
YoY Change | -18.78% | 24.0% | |
INVESTING ACTIVITIES | |||
Capital Expenditures | $102.0K | $287.0K | |
YoY Change | -64.46% | -62.04% | |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $778.0K | -$40.18M | |
YoY Change | -101.94% | 41.04% | |
Cash From Investing Activities | $676.0K | -$40.47M | |
YoY Change | -101.67% | 38.37% | |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $60.27M | ||
YoY Change | 398.68% | ||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -152.0K | 59.55M | |
YoY Change | -100.26% | 397.01% | |
NET CHANGE | |||
Cash From Operating Activities | -27.49M | -33.85M | |
Cash From Investing Activities | 676.0K | -40.47M | |
Cash From Financing Activities | -152.0K | 59.55M | |
Net Change In Cash | -26.97M | -14.76M | |
YoY Change | 82.68% | -66.87% | |
FREE CASH FLOW | |||
Cash From Operating Activities | -$27.49M | -$33.85M | |
Capital Expenditures | $102.0K | $287.0K | |
Free Cash Flow | -$27.59M | -$34.13M | |
YoY Change | -19.17% | 21.68% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001994702 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
CY2024Q3 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2023Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
||
CY2024Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2023Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
||
CY2024Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
||
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
||
CY2024Q1 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.219 | |
CY2024Q1 | us-gaap |
Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
|
0.219 | |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2024-09-30 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2024 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
001-41947 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
Kyverna Therapeutics, Inc. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
83-1365411 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
5980 Horton St. | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
STE 550 | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Emeryville | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
CA | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
94608 | ||
dei |
City Area Code
CityAreaCode
|
(510) | ||
dei |
Local Phone Number
LocalPhoneNumber
|
925-2492 | ||
dei |
Security12b Title
Security12bTitle
|
Common Stock, par value $0.00001 per share | ||
dei |
Trading Symbol
TradingSymbol
|
KYTX | ||
dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | ||
dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
CY2024Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
43171612 | |
CY2024Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
104663000 | |
CY2023Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
34647000 | |
CY2024Q3 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
216924000 | |
CY2023Q4 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
22896000 | |
CY2024Q3 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
3787000 | |
CY2023Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
3121000 | |
CY2024Q3 | us-gaap |
Assets Current
AssetsCurrent
|
325374000 | |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
60664000 | |
CY2024Q3 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
564000 | |
CY2023Q4 | us-gaap |
Restricted Cash Noncurrent
RestrictedCashNoncurrent
|
565000 | |
CY2024Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
3151000 | |
CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
2326000 | |
CY2024Q3 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
7153000 | |
CY2023Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
6494000 | |
CY2024Q3 | us-gaap |
Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
|
1078000 | |
CY2023Q4 | us-gaap |
Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
|
1790000 | |
CY2024Q3 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
1876000 | |
CY2023Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
3356000 | |
CY2024Q3 | us-gaap |
Assets
Assets
|
339196000 | |
CY2023Q4 | us-gaap |
Assets
Assets
|
75195000 | |
CY2024Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
9932000 | |
CY2023Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
4358000 | |
CY2024Q3 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
4440000 | |
CY2023Q4 | us-gaap |
Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
|
2812000 | |
CY2024Q3 | kytx |
Accrued License Expense Related Party
AccruedLicenseExpenseRelatedParty
|
6250000 | |
CY2023Q4 | kytx |
Accrued License Expense Related Party
AccruedLicenseExpenseRelatedParty
|
6250000 | |
CY2024Q3 | kytx |
Other Accrued Expenses And Current Liabilities
OtherAccruedExpensesAndCurrentLiabilities
|
6432000 | |
CY2023Q4 | kytx |
Other Accrued Expenses And Current Liabilities
OtherAccruedExpensesAndCurrentLiabilities
|
3519000 | |
CY2024Q3 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
3000000 | |
CY2023Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
1964000 | |
CY2024Q3 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
931000 | |
CY2023Q4 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
956000 | |
CY2024Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
30985000 | |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
19859000 | |
CY2024Q3 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
4968000 | |
CY2023Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
5238000 | |
CY2024Q3 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
237000 | |
CY2023Q4 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
921000 | |
CY2024Q3 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
296000 | |
CY2024Q3 | us-gaap |
Liabilities
Liabilities
|
36486000 | |
CY2023Q4 | us-gaap |
Liabilities
Liabilities
|
26018000 | |
CY2024Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
10000000 | |
CY2024Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.00001 | |
CY2024Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2024Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
0 | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | |
CY2023Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | |
CY2024Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.00001 | |
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.00001 | |
CY2024Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
490000000 | |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
140492016 | |
CY2024Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
43167337 | |
CY2024Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
43167337 | |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
1250103 | |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
1250103 | |
CY2024Q3 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
528588000 | |
CY2023Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
4642000 | |
CY2024Q3 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
153000 | |
CY2023Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
4000 | |
CY2024Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-226031000 | |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-136043000 | |
CY2024Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
302710000 | |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-131397000 | |
CY2024Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
339196000 | |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
75195000 | |
CY2024Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
29193000 | |
CY2023Q3 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
13644000 | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
78990000 | ||
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
32760000 | ||
CY2024Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
9577000 | |
CY2023Q3 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2638000 | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
22573000 | ||
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
8269000 | ||
CY2024Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
38770000 | |
CY2023Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
16282000 | |
us-gaap |
Operating Expenses
OperatingExpenses
|
101563000 | ||
us-gaap |
Operating Expenses
OperatingExpenses
|
41029000 | ||
CY2024Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-38770000 | |
CY2023Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-16282000 | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-101563000 | ||
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-41029000 | ||
CY2024Q3 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
4355000 | |
CY2023Q3 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
880000 | |
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
11784000 | ||
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
1493000 | ||
CY2024Q3 | us-gaap |
Interest Expense Nonoperating
InterestExpenseNonoperating
|
32000 | |
CY2023Q3 | us-gaap |
Interest Expense Nonoperating
InterestExpenseNonoperating
|
50000 | |
us-gaap |
Interest Expense Nonoperating
InterestExpenseNonoperating
|
115000 | ||
us-gaap |
Interest Expense Nonoperating
InterestExpenseNonoperating
|
140000 | ||
CY2024Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-45000 | |
CY2023Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-13000 | |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-94000 | ||
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-23000 | ||
CY2024Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
4278000 | |
CY2023Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
817000 | |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
11575000 | ||
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
1330000 | ||
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-34492000 | |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-15465000 | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-89988000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-39699000 | ||
CY2024Q3 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
190000 | |
CY2023Q3 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
5000 | |
us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
149000 | ||
us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
31000 | ||
CY2024Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
190000 | |
CY2023Q3 | us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
5000 | |
us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
149000 | ||
us-gaap |
Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
31000 | ||
CY2024Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-34302000 | |
CY2023Q3 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-15460000 | |
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-89839000 | ||
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-39668000 | ||
CY2024Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.8 | |
CY2024Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.8 | |
CY2023Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-23.27 | |
CY2023Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-23.27 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-2.45 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-2.45 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-62.75 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-62.75 | ||
CY2024Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
43155858 | |
CY2024Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
43155858 | |
CY2023Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
664656 | |
CY2023Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
664656 | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
36702183 | ||
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
36702183 | ||
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
632624 | ||
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
632624 | ||
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-131397000 | |
CY2024Q1 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
30686000 | |
CY2024Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
336164000 | |
CY2024Q1 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
180574000 | |
CY2024Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
64000 | |
CY2024Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
2278000 | |
CY2024Q1 | kytx |
Vesting Of Early Exercised Options And Restricted Stock
VestingOfEarlyExercisedOptionsAndRestrictedStock
|
6000 | |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-26693000 | |
CY2024Q1 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
-5000 | |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
360991000 | |
CY2024Q2 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
73000 | |
CY2024Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1284000 | |
CY2024Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-28803000 | |
CY2024Q2 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
-36000 | |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
333509000 | |
CY2024Q3 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
90000 | |
CY2024Q3 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
3413000 | |
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-34492000 | |
CY2024Q3 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
190000 | |
CY2024Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
302710000 | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-73997000 | |
CY2023Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
24000 | |
CY2023Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
468000 | |
CY2023Q1 | kytx |
Vesting Of Early Exercised Options And Restricted Stock
VestingOfEarlyExercisedOptionsAndRestrictedStock
|
18000 | |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-11143000 | |
CY2023Q1 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
18000 | |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-84612000 | |
CY2023Q2 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
51000 | |
CY2023Q2 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
36000 | |
CY2023Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
447000 | |
CY2023Q2 | kytx |
Vesting Of Early Exercised Options And Restricted Stock
VestingOfEarlyExercisedOptionsAndRestrictedStock
|
17000 | |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-13091000 | |
CY2023Q2 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
8000 | |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-97195000 | |
CY2023Q3 | us-gaap |
Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
|
49000 | |
CY2023Q3 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
310000 | |
CY2023Q3 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
521000 | |
CY2023Q3 | kytx |
Vesting Of Early Exercised Options And Restricted Stock
VestingOfEarlyExercisedOptionsAndRestrictedStock
|
18000 | |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-15465000 | |
CY2023Q3 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
|
5000 | |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-111806000 | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-89988000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-39699000 | ||
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
6975000 | ||
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1436000 | ||
us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
5428000 | ||
us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
510000 | ||
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
1570000 | ||
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
1245000 | ||
kytx |
Non Cash Lease Expense
NonCashLeaseExpense
|
1859000 | ||
kytx |
Non Cash Lease Expense
NonCashLeaseExpense
|
1266000 | ||
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
666000 | ||
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
207000 | ||
us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
995000 | ||
us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
37000 | ||
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
6034000 | ||
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
1104000 | ||
us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
1628000 | ||
us-gaap |
Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
|
444000 | ||
kytx |
Increase Decrease In Other Accrued Expenses And Current Liabilities
IncreaseDecreaseInOtherAccruedExpensesAndCurrentLiabilities
|
3278000 | ||
kytx |
Increase Decrease In Other Accrued Expenses And Current Liabilities
IncreaseDecreaseInOtherAccruedExpensesAndCurrentLiabilities
|
2327000 | ||
us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
296000 | ||
us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-1752000 | ||
us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-1216000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-77189000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-33847000 | ||
us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
362751000 | ||
us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
53862000 | ||
us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
174300000 | ||
us-gaap |
Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
13683000 | ||
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1673000 | ||
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
287000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-190124000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-40466000 | ||
us-gaap |
Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
|
341171000 | ||
us-gaap |
Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
|
59900000 | ||
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
227000 | ||
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
370000 | ||
us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
709000 | ||
us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
562000 | ||
us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
3361000 | ||
us-gaap |
Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
|
156000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
337328000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
59552000 | ||
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
70015000 | ||
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-14761000 | ||
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
35212000 | |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
38289000 | |
CY2024Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
105227000 | |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
23528000 | |
CY2024Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
104663000 | |
CY2023Q3 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
22967000 | |
CY2024Q3 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
564000 | |
CY2023Q3 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
561000 | |
CY2024Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
105227000 | |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
23528000 | |
kytx |
Conversion Of Redeemable Convertible Preferred Stock Into Common Stock On Completion Of Initial Public Offering Shares
ConversionOfRedeemableConvertiblePreferredStockIntoCommonStockOnCompletionOfInitialPublicOfferingShares
|
114556997 | ||
kytx |
Conversion Of Redeemable Convertible Preferred Stock Into Common Stock On Completion Of Initial Public Offering Amount Converted
ConversionOfRedeemableConvertiblePreferredStockIntoCommonStockOnCompletionOfInitialPublicOfferingAmountConverted
|
180574000 | ||
kytx |
Unpaid Deferred Offering Costs Included In Accounts Payable And Other Current Liabilities
UnpaidDeferredOfferingCostsIncludedInAccountsPayableAndOtherCurrentLiabilities
|
729000 | ||
us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
10000 | ||
kytx |
Non Cash Vesting Of Restricted Stock
NonCashVestingOfRestrictedStock
|
6000 | ||
kytx |
Non Cash Vesting Of Restricted Stock
NonCashVestingOfRestrictedStock
|
53000 | ||
kytx |
Right Of Use Asset Obtained In Exchange For Operating And Finance Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingAndFinanceLeaseLiability
|
2518000 | ||
kytx |
Right Of Use Asset Obtained In Exchange For Operating And Finance Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingAndFinanceLeaseLiability
|
854000 | ||
us-gaap |
Interest Paid Net
InterestPaidNet
|
115000 | ||
us-gaap |
Interest Paid Net
InterestPaidNet
|
140000 | ||
dei |
Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
|
2018-06-14 | ||
us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
On January 30, 2024, the Company’s shareholders approved and the Company effected a reverse stock split of the shares of common stock at a ratio of 1-for-4.5511 (the “Reverse Stock Split”). The number of authorized shares and par value per share were not adjusted as a result of the Reverse Stock Split. All references to shares, restricted stock awards, restricted stock units and options to purchase common stock, share data, per share data, and related information contained in the financial statements have been retrospectively adjusted to reflect the effect of the Reverse Stock Split for all periods presented. The conversion ratios for each series of the Company’s redeemable convertible preferred stock, which was automatically converted into shares of common stock upon the closing of the IPO, were proportionally adjusted. | ||
CY2024Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-226000000 | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-90000000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-39700000 | ||
CY2024Q3 | us-gaap |
Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
|
321600000 | |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. On an ongoing basis, the Company evaluates its estimates and assumptions, including those related to research and development accrued expenses, valuation of its common stock prior to the IPO, stock-based compensation, valuation of deferred tax assets and uncertain income tax positions. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the amount reported as revenue and expenses that are not readily apparent from other sources. Actual results may differ materially from those estimates.</span></p> | ||
us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
1 | ||
us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | ||
CY2024Q3 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
318883000 | |
CY2024Q3 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
154000 | |
CY2024Q3 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
1000 | |
CY2024Q3 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
319036000 | |
CY2024Q3 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
102100000 | |
CY2024Q3 | us-gaap |
Marketable Securities Current
MarketableSecuritiesCurrent
|
216900000 | |
CY2023Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
22892000 | |
CY2023Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
4000 | |
CY2023Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
22896000 | |
CY2024Q3 | kytx |
Impairment Loss On Debt Securities Available For Sale
ImpairmentLossOnDebtSecuritiesAvailableForSale
|
0 | |
kytx |
Impairment Loss On Debt Securities Available For Sale
ImpairmentLossOnDebtSecuritiesAvailableForSale
|
0 | ||
CY2023Q3 | kytx |
Impairment Loss On Debt Securities Available For Sale
ImpairmentLossOnDebtSecuritiesAvailableForSale
|
0 | |
kytx |
Impairment Loss On Debt Securities Available For Sale
ImpairmentLossOnDebtSecuritiesAvailableForSale
|
0 | ||
CY2024Q3 | us-gaap |
Interest Receivable Noncurrent
InterestReceivableNoncurrent
|
300000 | |
CY2023Q4 | us-gaap |
Interest Receivable Noncurrent
InterestReceivableNoncurrent
|
0 | |
CY2024Q3 | us-gaap |
Debt Securities Available For Sale Accrued Interest Writeoff
DebtSecuritiesAvailableForSaleAccruedInterestWriteoff
|
0 | |
us-gaap |
Debt Securities Available For Sale Accrued Interest Writeoff
DebtSecuritiesAvailableForSaleAccruedInterestWriteoff
|
0 | ||
CY2024Q3 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
6497000 | |
CY2023Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
4814000 | |
CY2024Q3 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
3346000 | |
CY2023Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2488000 | |
CY2024Q3 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
3151000 | |
CY2023Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
2326000 | |
CY2024Q3 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
300000 | |
CY2023Q3 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
200000 | |
us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
900000 | ||
us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
600000 | ||
kytx |
Milestone Payments Achieved Or Probable
MilestonePaymentsAchievedOrProbable
|
0 | ||
CY2023 | kytx |
Milestone Payments Achieved Or Probable
MilestonePaymentsAchievedOrProbable
|
0 | |
CY2024Q3 | us-gaap |
Royalty Guarantees Commitments Amount
RoyaltyGuaranteesCommitmentsAmount
|
0 | |
CY2023Q4 | us-gaap |
Royalty Guarantees Commitments Amount
RoyaltyGuaranteesCommitmentsAmount
|
0 | |
us-gaap |
Lessee Operating Lease Description
LesseeOperatingLeaseDescription
|
As of September 30, 2024, the Company leased 68,153 square feet of office and laboratory space in Emeryville, California under operating leases which have terms through February 2027. | ||
CY2024Q3 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
854000 | |
CY2023Q3 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
602000 | |
us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
2398000 | ||
us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
1821000 | ||
CY2024Q3 | us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
237000 | |
CY2023Q3 | us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
216000 | |
us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
712000 | ||
us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
607000 | ||
CY2024Q3 | us-gaap |
Finance Lease Interest Expense
FinanceLeaseInterestExpense
|
33000 | |
CY2023Q3 | us-gaap |
Finance Lease Interest Expense
FinanceLeaseInterestExpense
|
49000 | |
us-gaap |
Finance Lease Interest Expense
FinanceLeaseInterestExpense
|
115000 | ||
us-gaap |
Finance Lease Interest Expense
FinanceLeaseInterestExpense
|
140000 | ||
us-gaap |
Short Term Lease Cost
ShortTermLeaseCost
|
1000 | ||
CY2024Q3 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
262000 | |
CY2023Q3 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
246000 | |
us-gaap |
Variable Lease Cost
VariableLeaseCost
|
814000 | ||
us-gaap |
Variable Lease Cost
VariableLeaseCost
|
730000 | ||
CY2024Q3 | us-gaap |
Lease Cost
LeaseCost
|
1386000 | |
CY2023Q3 | us-gaap |
Lease Cost
LeaseCost
|
1113000 | |
us-gaap |
Lease Cost
LeaseCost
|
4039000 | ||
us-gaap |
Lease Cost
LeaseCost
|
3299000 | ||
CY2024Q3 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
811000 | |
CY2023Q3 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
602000 | |
us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
2245000 | ||
us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
1769000 | ||
CY2024Q3 | us-gaap |
Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
|
33000 | |
CY2023Q3 | us-gaap |
Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
|
49000 | |
us-gaap |
Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
|
115000 | ||
us-gaap |
Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
|
140000 | ||
CY2024Q3 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
241000 | |
CY2023Q3 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
206000 | |
us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
709000 | ||
us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
562000 | ||
us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
2518000 | ||
CY2023Q3 | us-gaap |
Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
|
110000 | |
us-gaap |
Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
|
854000 | ||
CY2024Q3 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
816000 | |
CY2024Q3 | us-gaap |
Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
|
274000 | |
CY2024Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
3563000 | |
CY2024Q3 | us-gaap |
Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
|
887000 | |
CY2024Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
4046000 | |
CY2024Q3 | us-gaap |
Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
|
179000 | |
CY2024Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
446000 | |
CY2024Q3 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
8871000 | |
CY2024Q3 | us-gaap |
Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
|
1340000 | |
CY2024Q3 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
903000 | |
CY2024Q3 | us-gaap |
Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
|
172000 | |
CY2024Q3 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
7968000 | |
CY2024Q3 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
1168000 | |
CY2024Q3 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
3000000 | |
CY2024Q3 | us-gaap |
Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
|
931000 | |
CY2024Q3 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
4968000 | |
CY2024Q3 | us-gaap |
Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
|
237000 | |
CY2024Q3 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P2Y4M24D | |
CY2024Q3 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.09 | |
CY2024Q3 | us-gaap |
Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
|
P1Y3M18D | |
CY2024Q3 | us-gaap |
Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
|
0.11 | |
CY2023Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P3Y1M6D | |
CY2023Q4 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.08 | |
CY2023Q4 | us-gaap |
Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
|
P2Y | |
CY2023Q4 | us-gaap |
Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
|
0.11 | |
CY2024Q1 | us-gaap |
Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
|
25171265 | |
CY2024Q1 | us-gaap |
Temporary Equity Shares Issued
TemporaryEquitySharesIssued
|
0 | |
CY2024Q3 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
12407880 | |
CY2023Q4 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
29619628 | |
CY2022Q4 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
349321 | |
CY2022Q4 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
1100000 | |
CY2022Q4 | us-gaap |
Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
|
0.0427 | |
CY2022Q4 | kytx |
Debt Instrument Maturity Month Year
DebtInstrumentMaturityMonthYear
|
2027-12 | |
CY2024Q1 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
1100000 | |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
4310034 | |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
4.09 | |
CY2023 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P9Y1M2D | |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
11810000 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
3539804 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
8.29 | ||
us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
420290 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
3.15 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
312739 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
10.18 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
4031 | ||
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
4.42 | ||
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
7112778 | |
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
5.97 | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P7Y6M7D | ||
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
2854000 | |
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
1851204 | |
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
3.55 | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P6Y5M4D | ||
CY2024Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
2486000 | |
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
|
7112778 | |
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
|
5.97 | |
us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
|
P7Y6M7D | ||
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
|
2854000 | |
CY2023 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
349321 | |
CY2024Q3 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
|
885937 | |
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
5.43 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
6.43 | ||
CY2023Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
3.32 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
3.01 | ||
CY2024Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
100000 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
3500000 | ||
CY2023Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
100000 | |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
200000 | ||
CY2024Q3 | kytx |
Repurchase Liability Related To Unvested Shares
RepurchaseLiabilityRelatedToUnvestedShares
|
0 | |
us-gaap |
Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
|
0 | ||
CY2023 | us-gaap |
Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
|
8125 | |
CY2023 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
349321 | |
CY2024Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3413000 | |
CY2023Q3 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
521000 | |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
6975000 | ||
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1436000 | ||
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-34492000 | |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-15465000 | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-89988000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
-39699000 | ||
CY2024Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
43155858 | |
CY2024Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
43155858 | |
CY2023Q3 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
664656 | |
CY2023Q3 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
664656 | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
36702183 | ||
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
36702183 | ||
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
632624 | ||
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
632624 | ||
CY2024Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.8 | |
CY2024Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.8 | |
CY2023Q3 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-23.27 | |
CY2023Q3 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-23.27 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-2.45 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-2.45 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-62.75 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-62.75 | ||
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
7657629 | ||
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
27891642 | ||
CY2024Q3 | us-gaap |
Deferred Offering Costs
DeferredOfferingCosts
|
0 |